Elan complete royalty rights deal

Irish pharmaceutical firm Elan has completed the acquisition of the royalty rights of three drugs from Pharma Operating.

Irish pharmaceutical firm Elan has completed the acquisition of the royalty rights of three drugs from Pharma Operating.

Elan said this morning that it has completed the purchase of the rights in respect of Zonegran, Frova and Zanaflex for $99.6m (€83.75m).

You have reached your article limit. Already a subscriber? Sign in

Clubber TV and Irish Examiner logos in offer banner

Every Match. Every Story.

One Ultimate Bundle

No obligation. Ts&Cs apply.

More in this section

The Business Hub

Newsletter

News and analysis on business, money and jobs from Munster and beyond by our expert team of business writers.

Cookie Policy Privacy Policy Brand Safety FAQ Help Contact Us Terms and Conditions

© Examiner Echo Group Limited